PK and PD of Drugs for Nontuberculous Mycobacterial Diseases in Dutch Patients

NCT01051752 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2012-05-22

No results posted yet for this study

Summary

A prospective observational study in which pharmacokinetic and pharmacodynamic parameters are evaluated in a cohort of patients with NTM diseases.

Conditions

  • Nontuberculous Mycobacterial Diseases

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Rob Aarnoutse, Pharm D PhD · Radboud University Medical Center

  • Jan- Willem Alffenaar, PharmD PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-03-31
Completion
2011-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01051752 on ClinicalTrials.gov